A retrospective analysis of malnutrition risk, nutritional support and outcomes in COVID-19 patients

Bell, James Andrew; Heyer, Nicola; Greenstein, A; Fragkos, Konstantinos; Baxter-Derrington, Christopher; Mehta, Shameer

doi:10.1016/j.clnesp.2022.05.017

Cited by 5 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hypoalbuminemia could represent a subtle indicator of malnourishment. The nutritional status of patients has been a concern in the literature, as a high percentage of ICU COVID-19 patients seems to be at severe risk of malnourishment, and early studies have shown a correlation with increased length of ICU stay and mortality [ 21 , 22 , 23 ]. Unfortunately, no further data are available in our study to support such a correlation with fungal infections, and only a hypothesis to be tested in a future study can be made.…”

Section: Discussionmentioning

confidence: 99%

Fungal Infections in the ICU during the COVID-19 Era: Descriptive and Comparative Analysis of 178 Patients

Koukaki

Rovina

Tzannis

et al. 2022

JoF

View full text Add to dashboard Cite

Background: COVID-19-associated fungal infections seem to be a concerning issue. The aim of this study was to assess the incidence of fungal infections, the possible risk factors, and their effect on outcomes of critically ill patients with COVID-19. Methods: A retrospective observational study was conducted in the COVID-19 ICU of the First Respiratory Department of National and Kapodistrian University of Athens in Sotiria Chest Diseases Hospital between 27 August 2020 and 10 November 2021. Results: Here, 178 patients were included in the study. Nineteen patients (10.7%) developed fungal infection, of which five had COVID-19 associated candidemia, thirteen had COVID-19 associated pulmonary aspergillosis, and one had both. Patients with fungal infection were younger, had a lower Charlson Comorbidity Index, and had a lower PaO2/FiO2 ratio upon admission. Regarding health-care factors, patients with fungal infections were treated more frequently with Tocilizumab, a high regimen of dexamethasone, continuous renal replacement treatment, and were supported more with ECMO. They also had more complications, especially infections, and subsequently developed septic shock more frequently. Finally, patients with fungal infections had a longer length of ICU stay, as well as length of mechanical ventilation, although no statistically significant difference was reported on 28-day and 90-day mortality. Conclusions: Fungal infections seem to have a high incidence in COVID-19 critically ill patients and specific risk factors are identified. However, fungal infections do not seem to burden on mortality.

show abstract

Section: Discussionmentioning

confidence: 99%